Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Tom Lassar

Cardiovascular Disease Cleveland, OH Medical Doctor

NPI 1487670048 CMS profile 889034

11100 Euclid Ave, Cleveland, OH 44106

Open in the dashboard

General payments

$21,215

84 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Tom Lassar of Cleveland, OH is reported in the CMS Open Payments database as having received $21,215 across 84 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $247 2
2023 General $266 3
2021 General $618 4
2020 General $10,435 14
2019 General $9,649 61

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tom Lassar
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Tom Lassar were reported at $0. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Tom Lassar Cardiovascular Disease median Middle half National median
2019 $9,649 $450 $127–$1,392 $163
2020 $10,435 $242 $77–$751 $114
2021 $618 $335 $101–$1,037 $132
2022 $0 $395 $121–$1,211 $149
2023 $266 $443 $136–$1,283 $160
2024 $247 $450 $136–$1,323 $164
2025 $0 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Chiesi USA, Inc. $16,690 22 payments
  2. Janssen Scientific Affairs, LLC $2,000 1 payment
  3. Abiomed $285 4 payments
  4. AstraZeneca Pharmaceuticals LP $252 8 payments
  5. Pfizer Inc. $248 2 payments
  6. Abbott Laboratories $201 2 payments
  7. Janssen Pharmaceuticals, Inc $192 8 payments
  8. Novartis Pharmaceuticals Corporation $161 12 payments
  9. Philips Electronics North America Corporation $147 3 payments
  10. Teleflex LLC $145 1 payment
  11. Other $895 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Honoraria $8,350 5 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,950 3 payments
  3. Food and Beverage $2,977 66 payments
  4. Consulting Fee $2,000 1 payment
  5. Travel and Lodging $854 5 payments
  6. Gift $75 1 payment
  7. Education $8 3 payments
Products named General payments · program years 2019–2024
  1. KENGREAL $16,095 20 payments
  2. XARELTO $2,199 10 payments
  3. Impella $285 4 payments
  4. ENTRESTO $161 12 payments
  5. GUIDELINER $145 1 payment
  6. FLOWTRIEVER CATHETER, S $137 1 payment
  7. CT THROMBECTOMY SYSTEM KIT $137 1 payment
  8. VYNDAQEL $123 1 payment
  9. IGT D Coronary $120 2 payments
  10. CARDIOFORM Septal Occluder $118 1 payment
  11. Other $872 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

84 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record